Transversus Abdominis Plane Block After Robot-assisted Laparocopic Hysterectomy

Effekt of Transversus Abdominis Plane (TAP) Block After Robot-assisted Laparocopic Hysterectomy

Status

Terminated

Phases

Phase 4

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT01504386

Acronym

TAP-block

Enrollment

Registered

2012-01-05

Start date

2011-12-31

Completion date

2013-07-31

Last updated

2013-08-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hysterectomy

Brief summary

The purpose of this study is to investigate the effectiveness of Transversus Abdominis Plane (TAP) block as a part of a multimodal postoperative pain management after robot-assisted laparoscopic hysterecomy.

Interventions

PROCEDURETAP block

Bilateral UL-guided TAP block with 20 ml of ropivacaine 0.5 %

PROCEDUREPlacebo TAP block

Bilateral placement of 20 ml of saline 0.9 % in the transversus abdominis plane

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender

FEMALE

Age

18 Years to 80 Years

Healthy volunteers

Inclusion criteria

* Age 18-80 * BMI 17-40 * Written consent * Can cooperate

Exclusion criteria

* Drug and alcohol abuse * Consumption of opioids * Drug allergy * Infection at insertion point of needle

Design outcomes

Primary

Measure	Time frame	Description
Total opioid consumption	0-24 hours	Opioid consumption via PCA-pump

Secondary

Measure	Time frame	Description
Pain during rest and cough	1,2,4,8,18 and 24 hours	VAS-pain score at rest and at cough
Postoperative nausea and vomiting	1,2,4,8,18 and 24 hours	Nausea score 0-3 No. of vomits

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026